Idecabtagene Vicleucel in Relapsed Myeloma. Reply
N Engl J Med
.
2021 Jun 17;384(24):2357-2358.
doi: 10.1056/NEJMc2105069.
Authors
Nikhil C Munshi
1
,
Kristen Hege
2
,
Jesús San-Miguel
3
Affiliations
1
Dana-Farber Cancer Institute, Boston, MA nikhil_munshi@dfci.harvard.edu.
2
Bristol Myers Squibb, Princeton, NJ.
3
Clínica Universidad de Navarra, Pamplona, Spain.
PMID:
34133871
DOI:
10.1056/NEJMc2105069
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Multiple Myeloma* / drug therapy
Neoplasm Recurrence, Local